Efficacy of Venetoclax in Combination With Rituximab in Waldenstr öm's Macroglobulinemia

Condition:   Waldenstrom Macroglobulinemia Interventions:   Drug: Venetoclax; Rituximab;   Drug: DRC Sponsors:   University of Ulm;   Institute for Medical Informatics, Biometry and Epidemiology, University of Munich;   Zentrum für Klinische Studien Ulm;   AbbVie;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials